Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma.

論文 Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma.

著者 Kaira K, Imai H, Kagamu H.